Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 154

Results For "Dash"

1811 News Found

Japan tops CPhI ‘API Quality’ ranking for second year
News | March 13, 2022

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers


Aurobindo Pharma trains its managers to be `future ready’
News | March 11, 2022

Aurobindo Pharma trains its managers to be `future ready’

Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready


Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals
interviews | March 10, 2022

Glaucoma is the leading cause of irreversible blindness in India: Mr. Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals

As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma


Vestige launches nutritional supplement for women
Healthcare | March 10, 2022

Vestige launches nutritional supplement for women

It has blended 36 important ingredients for a woman’s health, which has a mix of natural extracts, amino acids, multivitamins and minerals


Molecular Health and researchers prove new approach to anticipate molecular causation
Biotech | March 10, 2022

Molecular Health and researchers prove new approach to anticipate molecular causation

The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts


USFDA approves Evoke Spinal Cord Stimulation System
Drug Approval | March 09, 2022

USFDA approves Evoke Spinal Cord Stimulation System

Transformative closed-loop technology senses the spinal cord's response to stimulation and instantaneously adjusts therapy to sustain durable, optimized treatment


OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations
Biotech | March 09, 2022

OpenEye Scientific and Gaussian collaboration expands quantum chemistry calculations

Using Orion, pharmaceutical and biotechnology companies, as well as any industrial researcher who wishes to perform electronic structure calculations, can gain access to elastic and flexible computational resources in the Cloud


SRL Diagnostics report indicates women neglect routine tests
Clinical Trials | March 09, 2022

SRL Diagnostics report indicates women neglect routine tests

Routine tests undertaken by women dropped by 35% in 2020


AstraZeneca partners with Indian Society of Nephrology to promote kidney health
Public Health | March 09, 2022

AstraZeneca partners with Indian Society of Nephrology to promote kidney health

Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health


Novartis, Voyager Therapeutics reach license deal for gene therapy vectors to combat neurological diseases
Biotech | March 09, 2022

Novartis, Voyager Therapeutics reach license deal for gene therapy vectors to combat neurological diseases

Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders